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Cultural Competence: Essential Measurements of Quality for Managed
Care Organizations
Abstract
We are currently witnessing a radical change in the health care system in the United States as a result of the
managed care juggernaut. Driven by the imperative to stem increasing health care costs, managed care seeks to
save money by “managing” health care utilization and narrowing the choices available to health care
consumers. Although both cost-saving strategies are effective, they also present a potential threat to quality of
care. As HEDIS and other measures of quality are revised, physicians must establish guidelines for quality of
care that support the burgeoning managed health care environment. In developing these guidelines and
measures, two important trends must be acknowledged and addressed. First, managed care was formerly
confined mostly to middle class populations but now envelops many more diverse and vulnerable groups,
including Medicaid, Medicare, and minority populations [1]. Second, providing care within a managed care
environment requires attention to the population of “covered lives” in addition to individual patients.
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We are currently witnessing a radical change in the health care system in the United States as 
a result of the managed care juggernaut. Driven by 
the imperative to stem increasing health care costs, 
managed care seeks to save money by "managing" 
health care utilization and narrowing the choices 
available to health care consumers. Although both 
cost-saving strategies are effective, they also present 
a potential threat to quality of care. As HEDIS and 
other measures of quality are revised, physicians 
must establish guidelines for quality of care that 
support the burgeoning managed health care envi-
ronment. In developing these guidelines and mea-
sures, two important trends must be acknowledged 
and addressed. First, managed care was formerly 
confined mostly to middle class populations but now 
envelops many more diverse and vulnerable groups, 
including Medicaid, Medicare, and minority popu-
lations (1). Second, providing care within a man-
aged care environment requires attention to the 
population of "covered lives" in addition to individ-
ual patients. 
Simultaneously, the demographic characteristics 
of the United States are rapidly changing. By the 
year 2000, roughly 25% of the U.S. population will 
be members of "minority" groups (2). Projections 
suggest that by the year 2050, ethnic subpopulations 
will make up 47.5% of the total U.S. population (2), 
and that by the year 2056, whites will probably be a 
minority group (3). Furthermore, minority groups 
are not monolithic, and we must take into account 
the considerable diversity that exists within U.S. 
ethnic subpopulations (4). In addition, many of 
these subpopulations remain disproportionately rep-
resented in low-income categories (5), and this too 
must be factored into guidelines for quality of care. 
Of course, the hardest part of this process is 
actually formulating a set of viable guidelines that 
will improve the ability of a managed care organi-
zation to meet high quality standards in all popula-
tions and that will translate into measures of ac-
countability. Such an endeavor is fraught with 
pitfalls. But the first steps must be to acknowledge 
the necessity of creating these guidelines and to 
conceptualize the components of such guidelines. 
On this basis, we conceptualize "cultural compe-
tence" as the demonstrated awareness and integra-
tion of three population-specific issues: health-re-
lated beliefs and cultural values, disease incidence 
and prevalence, and treatment efficacy. But perhaps 
the most significant aspect of this concept is the 
inclusion and integration of three areas that are 
usually considered separately when they are consid-
ered at all. 
The value of each component is distinct. First, 
the importance of "cultural sensitivity" or "cultural 
appropriateness" in delivering health care to a cul-
turally diverse patient population is undeniable, and 
it is recognized as one variable in the measurement 
of physician accountability (6). That belief systems 
play a critical role in medical care has long been 
acknowledged (7), but interest in the sociocultural 
aspects of health care has recently intensified as it 
becomes increasingly clear that the benefit of an 
approach to healing is often population specific (8, 
9). Failure to address the very real issues of cross-
cultural communication and variations in health be-
liefs in the clinical setting certainly threatens patient 
satisfaction and potentially threatens clinical out-
comes. Furthermore, the socioeconomic divide that 
may exist between the culture of managed care sys-
tems and the cultures of vulnerable populations acts 
as a formidable nonfinancial barrier to care, and 
this too must be considered (10). Managed care has 
distinct values and expectations that emerged from 
and are reinforced by the dominant youth-oriented 
culture in the United States. The belief systems and 
perspectives of cultural subpopulations, which are 
equally valid, may give rise to health-related behav-
iors that clash with the expectations of the health 
plan. As they penetrate into Medicare, Medicaid, 
and minority populations, successful managed care 
organizations will attempt to negotiate these differ-
ences respectfully and proactively—while constantly 
measuring their own performance. 
Second, we believe that effectively managing health 
care resources for any population requires an epide-
miologic perspective. Because disease incidence var-
ies among racial and ethnic subpopulations, man-
aged care organizations that do not have accurate 
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epidemiologic data with which to guide decisions 
about health education, screening, and treatment 
programs will probably not use their limited re-
sources most effectively in addressing diseases most 
prevalent in their member population. For example, 
some subpopulations within the United States 
have a greater incidence of non-insulin-dependent 
diabetes mellitus (11). Others are afflicted by and 
die from asthma disproportionately (12). Still oth-
ers, such as the Hmong Vietnamese, have a much 
greater risk for liver cancer than other cultural 
groups because of previous episodes of hepatitis. 
Providers who are not guided by such epidemiologic 
knowledge are much more likely to make errors in 
diagnosis and treatment, wasting resources and 
damaging lives (13). If acceptable standards of qual-
ity are to be maintained with fewer resources, man-
aged care organizations must routinely incorporate 
epidemiologic information into their programs and 
resource allocation decisions and must hold provid-
ers accountable for implementing practice strategies 
to meet the needs of the "lives covered." 
Third, a growing body of evidence indicates that 
the efficacy of treatments can vary among different 
populations and that it is critical that the expected 
differences be integrated into measurements of 
quality (14, 15). For example, some data indicate 
that responses to drugs such as angiotensin-convert-
ing enzyme inhibitors, diuretics, and /3-blockers dif-
fer according to race (16, 17), and other data sug-
gests that responses to /3-adrenergic agonists differ 
in black and white patients with asthma (18). Al-
though the cited studies highlight important differ-
ences in treatment response, they focus on individ-
ual patients, not on outcomes in entire populations. 
Clinical researchers are calling for increased efforts 
in exploring population-specific pharmacologic ef-
fects to help ensure accurate diagnosis of disease 
(15), as well as drug safety and efficacy for all 
populations (19). Effective managed care organiza-
tions that accept responsibility for all the popula-
tions they serve will be guided by an awareness of 
this issue and will maintain flexibility in diagnostic 
and treatment protocols or formularies. In an envi-
ronment in which delivering the most cost-effec-
tive—not necessarily the cheapest—treatment for 
the populations served will determine the reputation 
and financial success of a managed care organiza-
tion, more research and guideline development in 
this area are clearly needed. 
By way of illustration, some important indicators 
of cultural competence for managed care organiza-
tions whose "covered lives" include many minorities 
might include the effectiveness of an outreach program 
for Puerto Rican adolescents with asthma in con-
junction with population-based measures of re-
stricted activity caused by asthma; the percentage of 
pregnant women of low socioeconomic status who 
attend 90% of their prenatal visits beginning in the 
first trimester; mammography rates among minority 
women; and member satisfaction with language and 
cultural translation (or brokering) services (20). 
In conclusion, it is imperative at this juncture for 
the medical community to determine what consti-
tutes quality of care—particularly for vulnerable 
populations—and to formulate comprehensive and 
viable guidelines for achieving high-quality care in 
all populations. We believe that the concept of cul-
tural competence, when defined as the integration 
of three familiar concepts, generates new, powerful, 
and essential measures of high-quality care for pop-
ulations. Issues of quality and oversight are espe-
cially salient in a health care environment in which 
increasing numbers of lower-income, culturally di-
verse, possibly vulnerable populations are moving to 
a system of care based on limited choice. By includ-
ing cultural competence in assessments of quality 
and by implementing culturally competent systems 
of care, managed care organizations can make seri-
ous progress toward successfully meeting the health 
care needs of all U.S. populations. 
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